nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP3A4—Temozolomide—malignant glioma	0.129	1	CbGbCtD
Felbamate—GRIN2B—telencephalic ventricle—malignant glioma	0.04	0.242	CbGeAlD
Felbamate—Myeloid leukaemia—Temozolomide—malignant glioma	0.0339	0.0589	CcSEcCtD
Felbamate—Hemianopia—Temozolomide—malignant glioma	0.0308	0.0536	CcSEcCtD
Felbamate—Platelet disorder—Temozolomide—malignant glioma	0.0245	0.0426	CcSEcCtD
Felbamate—Edema cerebral—Carmustine—malignant glioma	0.0238	0.0413	CcSEcCtD
Felbamate—Edema cerebral—Temozolomide—malignant glioma	0.023	0.0399	CcSEcCtD
Felbamate—Status epilepticus—Temozolomide—malignant glioma	0.0151	0.0262	CcSEcCtD
Felbamate—Brain oedema—Carmustine—malignant glioma	0.0129	0.0224	CcSEcCtD
Felbamate—Acute leukaemia—Carmustine—malignant glioma	0.0129	0.0224	CcSEcCtD
Felbamate—Acute leukaemia—Temozolomide—malignant glioma	0.0124	0.0216	CcSEcCtD
Felbamate—Brain oedema—Temozolomide—malignant glioma	0.0124	0.0216	CcSEcCtD
Felbamate—GRIN2B—brainstem—malignant glioma	0.0108	0.0656	CbGeAlD
Felbamate—GRIN3A—telencephalon—malignant glioma	0.0106	0.0644	CbGeAlD
Felbamate—GRIN2B—telencephalon—malignant glioma	0.00959	0.0582	CbGeAlD
Felbamate—GRIN2A—brainstem—malignant glioma	0.00945	0.0573	CbGeAlD
Felbamate—Paranoid reaction—Carmustine—malignant glioma	0.00865	0.015	CcSEcCtD
Felbamate—GRIN2A—telencephalon—malignant glioma	0.00839	0.0509	CbGeAlD
Felbamate—GRIN2B—spinal cord—malignant glioma	0.00672	0.0408	CbGeAlD
Felbamate—GRIN2A—medulla oblongata—malignant glioma	0.00659	0.04	CbGeAlD
Felbamate—Cerebration impaired—Temozolomide—malignant glioma	0.00604	0.0105	CcSEcCtD
Felbamate—GRIN3A—central nervous system—malignant glioma	0.00603	0.0366	CbGeAlD
Felbamate—GRIN2A—midbrain—malignant glioma	0.00602	0.0365	CbGeAlD
Felbamate—GRIN2A—spinal cord—malignant glioma	0.00588	0.0357	CbGeAlD
Felbamate—Encephalopathy—Carmustine—malignant glioma	0.00573	0.00996	CcSEcCtD
Felbamate—GRIN2B—central nervous system—malignant glioma	0.00545	0.0331	CbGeAlD
Felbamate—Paranoia—Carmustine—malignant glioma	0.00539	0.00938	CcSEcCtD
Felbamate—GRIN2B—cerebellum—malignant glioma	0.00533	0.0323	CbGeAlD
Felbamate—Influenza-like symptoms—Temozolomide—malignant glioma	0.00497	0.00865	CcSEcCtD
Felbamate—Apathy—Temozolomide—malignant glioma	0.00497	0.00865	CcSEcCtD
Felbamate—Flat affect—Temozolomide—malignant glioma	0.00493	0.00857	CcSEcCtD
Felbamate—Stupor—Carmustine—malignant glioma	0.00492	0.00856	CcSEcCtD
Felbamate—Vaginal haemorrhage—Temozolomide—malignant glioma	0.0048	0.00834	CcSEcCtD
Felbamate—GRIN3A—brain—malignant glioma	0.00479	0.029	CbGeAlD
Felbamate—GRIN2A—central nervous system—malignant glioma	0.00477	0.0289	CbGeAlD
Felbamate—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00472	0.0082	CcSEcCtD
Felbamate—Necrosis—Carmustine—malignant glioma	0.00468	0.00814	CcSEcCtD
Felbamate—GRIN2A—cerebellum—malignant glioma	0.00466	0.0283	CbGeAlD
Felbamate—Coagulopathy—Temozolomide—malignant glioma	0.00456	0.00793	CcSEcCtD
Felbamate—Otitis media—Temozolomide—malignant glioma	0.00456	0.00793	CcSEcCtD
Felbamate—Rigors—Temozolomide—malignant glioma	0.00435	0.00756	CcSEcCtD
Felbamate—GRIN2B—brain—malignant glioma	0.00433	0.0263	CbGeAlD
Felbamate—Disturbance in attention—Temozolomide—malignant glioma	0.0041	0.00713	CcSEcCtD
Felbamate—Thinking abnormal—Carmustine—malignant glioma	0.00401	0.00698	CcSEcCtD
Felbamate—Drug interaction—Carmustine—malignant glioma	0.00396	0.00689	CcSEcCtD
Felbamate—Leukocytosis—Carmustine—malignant glioma	0.00391	0.0068	CcSEcCtD
Felbamate—GRIN2A—brain—malignant glioma	0.00378	0.023	CbGeAlD
Felbamate—Gait disturbance—Carmustine—malignant glioma	0.00377	0.00655	CcSEcCtD
Felbamate—Hearing impaired—Temozolomide—malignant glioma	0.00373	0.00649	CcSEcCtD
Felbamate—Gait disturbance—Temozolomide—malignant glioma	0.00364	0.00633	CcSEcCtD
Felbamate—Respiratory failure—Temozolomide—malignant glioma	0.00362	0.00629	CcSEcCtD
Felbamate—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00355	0.00618	CcSEcCtD
Felbamate—Urinary incontinence—Carmustine—malignant glioma	0.00355	0.00617	CcSEcCtD
Felbamate—Depressed level of consciousness—Carmustine—malignant glioma	0.00355	0.00617	CcSEcCtD
Felbamate—Influenza like illness—Temozolomide—malignant glioma	0.00345	0.006	CcSEcCtD
Felbamate—Urinary incontinence—Temozolomide—malignant glioma	0.00343	0.00596	CcSEcCtD
Felbamate—Depressed level of consciousness—Temozolomide—malignant glioma	0.00343	0.00596	CcSEcCtD
Felbamate—Coma—Carmustine—malignant glioma	0.00336	0.00584	CcSEcCtD
Felbamate—Aplastic anaemia—Temozolomide—malignant glioma	0.00333	0.0058	CcSEcCtD
Felbamate—Neoplasm—Carmustine—malignant glioma	0.00332	0.00578	CcSEcCtD
Felbamate—Neoplasm—Temozolomide—malignant glioma	0.00321	0.00558	CcSEcCtD
Felbamate—Abnormal vision—Carmustine—malignant glioma	0.00321	0.00557	CcSEcCtD
Felbamate—Mental disability—Carmustine—malignant glioma	0.00319	0.00555	CcSEcCtD
Felbamate—Sepsis—Carmustine—malignant glioma	0.00319	0.00555	CcSEcCtD
Felbamate—Abnormal vision—Temozolomide—malignant glioma	0.0031	0.00539	CcSEcCtD
Felbamate—Mental disability—Temozolomide—malignant glioma	0.00308	0.00536	CcSEcCtD
Felbamate—Thrombophlebitis—Carmustine—malignant glioma	0.00308	0.00536	CcSEcCtD
Felbamate—Thrombophlebitis—Temozolomide—malignant glioma	0.00298	0.00518	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00296	0.00515	CcSEcCtD
Felbamate—Vascular purpura—Temozolomide—malignant glioma	0.00288	0.00501	CcSEcCtD
Felbamate—Hepatic failure—Temozolomide—malignant glioma	0.00287	0.00499	CcSEcCtD
Felbamate—Hyponatraemia—Carmustine—malignant glioma	0.00268	0.00466	CcSEcCtD
Felbamate—Purpura—Temozolomide—malignant glioma	0.00267	0.00465	CcSEcCtD
Felbamate—Diplopia—Carmustine—malignant glioma	0.00267	0.00464	CcSEcCtD
Felbamate—CYP2E1—telencephalon—malignant glioma	0.00258	0.0157	CbGeAlD
Felbamate—Diplopia—Temozolomide—malignant glioma	0.00258	0.00448	CcSEcCtD
Felbamate—Face oedema—Carmustine—malignant glioma	0.00258	0.00448	CcSEcCtD
Felbamate—Affect lability—Temozolomide—malignant glioma	0.00254	0.00441	CcSEcCtD
Felbamate—Ataxia—Carmustine—malignant glioma	0.00251	0.00436	CcSEcCtD
Felbamate—Face oedema—Temozolomide—malignant glioma	0.00249	0.00433	CcSEcCtD
Felbamate—Mood swings—Temozolomide—malignant glioma	0.00244	0.00425	CcSEcCtD
Felbamate—Hypokalaemia—Carmustine—malignant glioma	0.00243	0.00422	CcSEcCtD
Felbamate—Ataxia—Temozolomide—malignant glioma	0.00242	0.00422	CcSEcCtD
Felbamate—Dehydration—Temozolomide—malignant glioma	0.0024	0.00417	CcSEcCtD
Felbamate—Muscular weakness—Carmustine—malignant glioma	0.00235	0.00409	CcSEcCtD
Felbamate—Hypokalaemia—Temozolomide—malignant glioma	0.00235	0.00408	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00232	0.00404	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00232	0.00404	CcSEcCtD
Felbamate—Dysphagia—Carmustine—malignant glioma	0.00231	0.00401	CcSEcCtD
Felbamate—Muscular weakness—Temozolomide—malignant glioma	0.00227	0.00395	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00227	0.00395	CcSEcCtD
Felbamate—Dysphagia—Temozolomide—malignant glioma	0.00223	0.00387	CcSEcCtD
Felbamate—Pancytopenia—Carmustine—malignant glioma	0.00219	0.00381	CcSEcCtD
Felbamate—Pancytopenia—Temozolomide—malignant glioma	0.00212	0.00368	CcSEcCtD
Felbamate—Dysuria—Temozolomide—malignant glioma	0.00208	0.00362	CcSEcCtD
Felbamate—Hyperglycaemia—Carmustine—malignant glioma	0.00208	0.00362	CcSEcCtD
Felbamate—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00207	0.0036	CcSEcCtD
Felbamate—Pneumonia—Carmustine—malignant glioma	0.00207	0.0036	CcSEcCtD
Felbamate—Depression—Carmustine—malignant glioma	0.00205	0.00356	CcSEcCtD
Felbamate—Photosensitivity reaction—Temozolomide—malignant glioma	0.00203	0.00354	CcSEcCtD
Felbamate—CYP2E1—medulla oblongata—malignant glioma	0.00203	0.0123	CbGeAlD
Felbamate—Weight increased—Temozolomide—malignant glioma	0.00203	0.00353	CcSEcCtD
Felbamate—Weight decreased—Temozolomide—malignant glioma	0.00202	0.00351	CcSEcCtD
Felbamate—Hyperglycaemia—Temozolomide—malignant glioma	0.00201	0.0035	CcSEcCtD
Felbamate—Urinary tract infection—Carmustine—malignant glioma	0.002	0.00347	CcSEcCtD
Felbamate—Pneumonia—Temozolomide—malignant glioma	0.002	0.00347	CcSEcCtD
Felbamate—Depression—Temozolomide—malignant glioma	0.00198	0.00344	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00197	0.00342	CcSEcCtD
Felbamate—Urinary tract infection—Temozolomide—malignant glioma	0.00193	0.00336	CcSEcCtD
Felbamate—Sinusitis—Temozolomide—malignant glioma	0.00186	0.00324	CcSEcCtD
Felbamate—Haemoglobin—Carmustine—malignant glioma	0.00186	0.00323	CcSEcCtD
Felbamate—Haemorrhage—Carmustine—malignant glioma	0.00185	0.00321	CcSEcCtD
Felbamate—Hallucination—Carmustine—malignant glioma	0.00184	0.00319	CcSEcCtD
Felbamate—CYP2E1—spinal cord—malignant glioma	0.00181	0.011	CbGeAlD
Felbamate—Haemoglobin—Temozolomide—malignant glioma	0.00179	0.00312	CcSEcCtD
Felbamate—Haemorrhage—Temozolomide—malignant glioma	0.00178	0.0031	CcSEcCtD
Felbamate—Hepatitis—Temozolomide—malignant glioma	0.00178	0.0031	CcSEcCtD
Felbamate—Visual impairment—Carmustine—malignant glioma	0.00178	0.00309	CcSEcCtD
Felbamate—Hallucination—Temozolomide—malignant glioma	0.00177	0.00309	CcSEcCtD
Felbamate—Pharyngitis—Temozolomide—malignant glioma	0.00177	0.00308	CcSEcCtD
Felbamate—Visual impairment—Temozolomide—malignant glioma	0.00172	0.00299	CcSEcCtD
Felbamate—Flushing—Carmustine—malignant glioma	0.00171	0.00298	CcSEcCtD
Felbamate—Erythema multiforme—Temozolomide—malignant glioma	0.00169	0.00293	CcSEcCtD
Felbamate—Flushing—Temozolomide—malignant glioma	0.00166	0.00288	CcSEcCtD
Felbamate—Alopecia—Carmustine—malignant glioma	0.00163	0.00284	CcSEcCtD
Felbamate—Chills—Temozolomide—malignant glioma	0.0016	0.00278	CcSEcCtD
Felbamate—Alopecia—Temozolomide—malignant glioma	0.00158	0.00274	CcSEcCtD
Felbamate—Dysgeusia—Temozolomide—malignant glioma	0.00152	0.00264	CcSEcCtD
Felbamate—Tremor—Carmustine—malignant glioma	0.00151	0.00262	CcSEcCtD
Felbamate—Anaemia—Carmustine—malignant glioma	0.00148	0.00258	CcSEcCtD
Felbamate—Agitation—Carmustine—malignant glioma	0.00148	0.00257	CcSEcCtD
Felbamate—CYP2E1—central nervous system—malignant glioma	0.00147	0.0089	CbGeAlD
Felbamate—Tremor—Temozolomide—malignant glioma	0.00145	0.00253	CcSEcCtD
Felbamate—Ill-defined disorder—Temozolomide—malignant glioma	0.00144	0.0025	CcSEcCtD
Felbamate—Leukopenia—Carmustine—malignant glioma	0.00144	0.0025	CcSEcCtD
Felbamate—Anaemia—Temozolomide—malignant glioma	0.00144	0.0025	CcSEcCtD
Felbamate—CYP2E1—cerebellum—malignant glioma	0.00143	0.0087	CbGeAlD
Felbamate—Agitation—Temozolomide—malignant glioma	0.00143	0.00248	CcSEcCtD
Felbamate—Malaise—Temozolomide—malignant glioma	0.0014	0.00243	CcSEcCtD
Felbamate—Leukopenia—Temozolomide—malignant glioma	0.00139	0.00242	CcSEcCtD
Felbamate—Hypertension—Carmustine—malignant glioma	0.00139	0.00241	CcSEcCtD
Felbamate—Palpitations—Temozolomide—malignant glioma	0.00137	0.00239	CcSEcCtD
Felbamate—Chest pain—Carmustine—malignant glioma	0.00137	0.00238	CcSEcCtD
Felbamate—Myalgia—Carmustine—malignant glioma	0.00137	0.00238	CcSEcCtD
Felbamate—Anxiety—Carmustine—malignant glioma	0.00136	0.00237	CcSEcCtD
Felbamate—Cough—Temozolomide—malignant glioma	0.00135	0.00236	CcSEcCtD
Felbamate—Hypertension—Temozolomide—malignant glioma	0.00134	0.00233	CcSEcCtD
Felbamate—Confusional state—Carmustine—malignant glioma	0.00132	0.0023	CcSEcCtD
Felbamate—Arthralgia—Temozolomide—malignant glioma	0.00132	0.0023	CcSEcCtD
Felbamate—Myalgia—Temozolomide—malignant glioma	0.00132	0.0023	CcSEcCtD
Felbamate—Anxiety—Temozolomide—malignant glioma	0.00132	0.00229	CcSEcCtD
Felbamate—Oedema—Carmustine—malignant glioma	0.00131	0.00228	CcSEcCtD
Felbamate—Discomfort—Temozolomide—malignant glioma	0.00131	0.00227	CcSEcCtD
Felbamate—Infection—Carmustine—malignant glioma	0.0013	0.00227	CcSEcCtD
Felbamate—Dry mouth—Temozolomide—malignant glioma	0.00129	0.00225	CcSEcCtD
Felbamate—Thrombocytopenia—Carmustine—malignant glioma	0.00128	0.00223	CcSEcCtD
Felbamate—Tachycardia—Carmustine—malignant glioma	0.00128	0.00223	CcSEcCtD
Felbamate—Confusional state—Temozolomide—malignant glioma	0.00128	0.00222	CcSEcCtD
Felbamate—Anaphylactic shock—Temozolomide—malignant glioma	0.00127	0.0022	CcSEcCtD
Felbamate—Oedema—Temozolomide—malignant glioma	0.00127	0.0022	CcSEcCtD
Felbamate—Infection—Temozolomide—malignant glioma	0.00126	0.00219	CcSEcCtD
Felbamate—Anorexia—Carmustine—malignant glioma	0.00125	0.00217	CcSEcCtD
Felbamate—Thrombocytopenia—Temozolomide—malignant glioma	0.00124	0.00216	CcSEcCtD
Felbamate—Hypotension—Carmustine—malignant glioma	0.00123	0.00213	CcSEcCtD
Felbamate—Hyperhidrosis—Temozolomide—malignant glioma	0.00122	0.00213	CcSEcCtD
Felbamate—Anorexia—Temozolomide—malignant glioma	0.00121	0.0021	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00119	0.00208	CcSEcCtD
Felbamate—Insomnia—Carmustine—malignant glioma	0.00119	0.00206	CcSEcCtD
Felbamate—GRIN2A—Post NMDA receptor activation events—RAF1—malignant glioma	0.00118	0.00905	CbGpPWpGaD
Felbamate—CYP3A4—central nervous system—malignant glioma	0.00118	0.00716	CbGeAlD
Felbamate—Paraesthesia—Carmustine—malignant glioma	0.00118	0.00205	CcSEcCtD
Felbamate—Dyspnoea—Carmustine—malignant glioma	0.00117	0.00203	CcSEcCtD
Felbamate—Somnolence—Carmustine—malignant glioma	0.00117	0.00203	CcSEcCtD
Felbamate—CYP2E1—brain—malignant glioma	0.00116	0.00707	CbGeAlD
Felbamate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00115	0.00201	CcSEcCtD
Felbamate—Insomnia—Temozolomide—malignant glioma	0.00115	0.00199	CcSEcCtD
Felbamate—Decreased appetite—Carmustine—malignant glioma	0.00114	0.00198	CcSEcCtD
Felbamate—Paraesthesia—Temozolomide—malignant glioma	0.00114	0.00198	CcSEcCtD
Felbamate—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00113	0.00868	CbGpPWpGaD
Felbamate—Dyspnoea—Temozolomide—malignant glioma	0.00113	0.00196	CcSEcCtD
Felbamate—Somnolence—Temozolomide—malignant glioma	0.00113	0.00196	CcSEcCtD
Felbamate—Constipation—Carmustine—malignant glioma	0.00112	0.00195	CcSEcCtD
Felbamate—Pain—Carmustine—malignant glioma	0.00112	0.00195	CcSEcCtD
Felbamate—Dyspepsia—Temozolomide—malignant glioma	0.00112	0.00194	CcSEcCtD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—malignant glioma	0.00111	0.00849	CbGpPWpGaD
Felbamate—Decreased appetite—Temozolomide—malignant glioma	0.0011	0.00192	CcSEcCtD
Felbamate—Fatigue—Temozolomide—malignant glioma	0.00109	0.0019	CcSEcCtD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—malignant glioma	0.00109	0.00834	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—CYP2C18—malignant glioma	0.00109	0.00834	CbGpPWpGaD
Felbamate—Pain—Temozolomide—malignant glioma	0.00108	0.00188	CcSEcCtD
Felbamate—Constipation—Temozolomide—malignant glioma	0.00108	0.00188	CcSEcCtD
Felbamate—Feeling abnormal—Carmustine—malignant glioma	0.00108	0.00188	CcSEcCtD
Felbamate—Gastrointestinal pain—Carmustine—malignant glioma	0.00107	0.00186	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—MDM2—malignant glioma	0.00106	0.00808	CbGpPWpGaD
Felbamate—Feeling abnormal—Temozolomide—malignant glioma	0.00104	0.00182	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—ERBB2—malignant glioma	0.00104	0.00796	CbGpPWpGaD
Felbamate—Abdominal pain—Carmustine—malignant glioma	0.00104	0.0018	CcSEcCtD
Felbamate—Body temperature increased—Carmustine—malignant glioma	0.00104	0.0018	CcSEcCtD
Felbamate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00104	0.0018	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—PIK3CB—malignant glioma	0.00103	0.00786	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00102	0.00777	CbGpPWpGaD
Felbamate—Urticaria—Temozolomide—malignant glioma	0.00101	0.00175	CcSEcCtD
Felbamate—GRIN2B—Post NMDA receptor activation events—RAF1—malignant glioma	0.00101	0.0077	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.001	0.00767	CbGpPWpGaD
Felbamate—Body temperature increased—Temozolomide—malignant glioma	0.001	0.00174	CcSEcCtD
Felbamate—Abdominal pain—Temozolomide—malignant glioma	0.001	0.00174	CcSEcCtD
Felbamate—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000984	0.00753	CbGpPWpGaD
Felbamate—Asthenia—Carmustine—malignant glioma	0.000941	0.00164	CcSEcCtD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—malignant glioma	0.000926	0.00709	CbGpPWpGaD
Felbamate—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000922	0.00706	CbGpPWpGaD
Felbamate—Asthenia—Temozolomide—malignant glioma	0.000909	0.00158	CcSEcCtD
Felbamate—Diarrhoea—Carmustine—malignant glioma	0.000897	0.00156	CcSEcCtD
Felbamate—Pruritus—Temozolomide—malignant glioma	0.000897	0.00156	CcSEcCtD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00088	0.00674	CbGpPWpGaD
Felbamate—GRIN2A—Reelin signaling pathway—PIK3CA—malignant glioma	0.00088	0.00674	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000869	0.00665	CbGpPWpGaD
Felbamate—Dizziness—Carmustine—malignant glioma	0.000867	0.00151	CcSEcCtD
Felbamate—Diarrhoea—Temozolomide—malignant glioma	0.000867	0.00151	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—BAD—malignant glioma	0.000848	0.00649	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—PTK2—malignant glioma	0.000838	0.00642	CbGpPWpGaD
Felbamate—Dizziness—Temozolomide—malignant glioma	0.000838	0.00146	CcSEcCtD
Felbamate—Vomiting—Carmustine—malignant glioma	0.000834	0.00145	CcSEcCtD
Felbamate—Rash—Carmustine—malignant glioma	0.000827	0.00144	CcSEcCtD
Felbamate—Dermatitis—Carmustine—malignant glioma	0.000826	0.00144	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000823	0.0063	CbGpPWpGaD
Felbamate—Headache—Carmustine—malignant glioma	0.000821	0.00143	CcSEcCtD
Felbamate—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000818	0.00626	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—NTRK2—malignant glioma	0.000817	0.00625	CbGpPWpGaD
Felbamate—Vomiting—Temozolomide—malignant glioma	0.000806	0.0014	CcSEcCtD
Felbamate—Rash—Temozolomide—malignant glioma	0.000799	0.00139	CcSEcCtD
Felbamate—Dermatitis—Temozolomide—malignant glioma	0.000798	0.00139	CcSEcCtD
Felbamate—Headache—Temozolomide—malignant glioma	0.000794	0.00138	CcSEcCtD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000783	0.006	CbGpPWpGaD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000779	0.00596	CbGpPWpGaD
Felbamate—Nausea—Carmustine—malignant glioma	0.000779	0.00135	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000773	0.00592	CbGpPWpGaD
Felbamate—Nausea—Temozolomide—malignant glioma	0.000753	0.00131	CcSEcCtD
Felbamate—GRIN2B—Reelin signaling pathway—PIK3CA—malignant glioma	0.000748	0.00573	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000742	0.00568	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—GDNF—malignant glioma	0.000724	0.00554	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—BAD—malignant glioma	0.000721	0.00552	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00072	0.00551	CbGpPWpGaD
Felbamate—GRIN2A—Reelin signaling pathway—AKT1—malignant glioma	0.000719	0.0055	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000714	0.00546	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000679	0.0052	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000677	0.00518	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00067	0.00513	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—NTRK1—malignant glioma	0.000666	0.0051	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—KDR—malignant glioma	0.00066	0.00505	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000635	0.00486	CbGpPWpGaD
Felbamate—GRIN2B—ErbB4 signaling events—PIK3CA—malignant glioma	0.000626	0.00479	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BCHE—malignant glioma	0.000612	0.00468	CbGpPWpGaD
Felbamate—GRIN2B—Reelin signaling pathway—AKT1—malignant glioma	0.000611	0.00468	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000596	0.00456	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—CAT—malignant glioma	0.000594	0.00455	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—IL1B—malignant glioma	0.00058	0.00444	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—CASP3—malignant glioma	0.000579	0.00443	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.000575	0.0044	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—BCHE—malignant glioma	0.000551	0.00422	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000551	0.00422	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—SPP1—malignant glioma	0.000541	0.00414	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000541	0.00414	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP2—malignant glioma	0.000539	0.00412	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—SLC6A3—malignant glioma	0.000518	0.00397	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—GDNF—malignant glioma	0.000517	0.00396	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000512	0.00392	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000505	0.00387	CbGpPWpGaD
Felbamate—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000501	0.00383	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—IL1B—malignant glioma	0.000493	0.00378	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—CASP3—malignant glioma	0.000492	0.00377	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000489	0.00374	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000471	0.00361	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—BCHE—malignant glioma	0.000469	0.00359	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000465	0.00356	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—BAD—malignant glioma	0.000446	0.00342	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—SLC6A3—malignant glioma	0.000441	0.00337	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP2B6—malignant glioma	0.000437	0.00335	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—APC—malignant glioma	0.000432	0.00331	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP2B6—malignant glioma	0.000431	0.0033	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—PTPN11—malignant glioma	0.000425	0.00325	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TNF—malignant glioma	0.000421	0.00322	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000417	0.00319	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000415	0.00318	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000409	0.00313	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000408	0.00313	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000408	0.00312	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP9—malignant glioma	0.000405	0.0031	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000403	0.00309	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—SOX2—malignant glioma	0.000392	0.003	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000382	0.00292	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP2C18—malignant glioma	0.000379	0.0029	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP2C18—malignant glioma	0.000374	0.00286	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TP53—malignant glioma	0.000371	0.00284	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000367	0.00281	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—malignant glioma	0.000363	0.00278	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TNF—malignant glioma	0.000358	0.00274	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000348	0.00266	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000347	0.00266	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—RAF1—malignant glioma	0.000339	0.0026	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP2B6—malignant glioma	0.000337	0.00258	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP2B6—malignant glioma	0.000333	0.00255	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000331	0.00253	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—MDM2—malignant glioma	0.000328	0.00251	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TP53—malignant glioma	0.000316	0.00242	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000312	0.00239	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—PTK2—malignant glioma	0.000311	0.00238	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000308	0.00236	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000307	0.00235	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTT1—malignant glioma	0.000307	0.00235	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CASP3—malignant glioma	0.000305	0.00233	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP2C18—malignant glioma	0.000292	0.00224	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP2C18—malignant glioma	0.000288	0.00221	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—PTGS1—malignant glioma	0.000287	0.0022	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—BRAF—malignant glioma	0.000281	0.00215	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000276	0.00211	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000262	0.002	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000261	0.002	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—FGFR1—malignant glioma	0.00026	0.00199	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—STAT3—malignant glioma	0.000256	0.00196	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000251	0.00192	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KDR—malignant glioma	0.000245	0.00188	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MET—malignant glioma	0.00024	0.00184	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—BRAF—malignant glioma	0.000239	0.00183	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000238	0.00182	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTT1—malignant glioma	0.000237	0.00181	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—MDM2—malignant glioma	0.000236	0.0018	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—RAF1—malignant glioma	0.000235	0.0018	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000228	0.00175	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PTK2—malignant glioma	0.000222	0.0017	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—PTPN11—malignant glioma	0.000222	0.0017	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—PTGS1—malignant glioma	0.000222	0.0017	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HES1—malignant glioma	0.000218	0.00167	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NCOR1—malignant glioma	0.000217	0.00166	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—RTEL1—malignant glioma	0.000215	0.00165	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTP1—malignant glioma	0.000213	0.00163	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTP1—malignant glioma	0.00021	0.0016	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000203	0.00155	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—MDM2—malignant glioma	0.0002	0.00153	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP2—malignant glioma	0.0002	0.00153	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.0002	0.00153	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—RAF1—malignant glioma	0.0002	0.00153	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—FGFR1—malignant glioma	0.000186	0.00142	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—RAF1—malignant glioma	0.000177	0.00136	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000176	0.00135	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—ERBB2—malignant glioma	0.000175	0.00134	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KDR—malignant glioma	0.000175	0.00134	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000173	0.00133	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MET—malignant glioma	0.000171	0.00131	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—RTEL1—malignant glioma	0.000166	0.00127	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—AKT1—malignant glioma	0.000165	0.00126	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NOTCH1—malignant glioma	0.000165	0.00126	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.000164	0.00126	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000162	0.00124	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PTPN11—malignant glioma	0.000158	0.00121	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PPARG—malignant glioma	0.000156	0.00119	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000152	0.00117	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP9—malignant glioma	0.00015	0.00115	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT2—malignant glioma	0.000147	0.00113	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP2—malignant glioma	0.000143	0.00109	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000142	0.00109	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—FGF2—malignant glioma	0.000136	0.00104	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—malignant glioma	0.000135	0.00103	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000133	0.00102	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—RAF1—malignant glioma	0.000126	0.000968	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ERBB2—malignant glioma	0.000125	0.000958	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—COX8A—malignant glioma	0.000123	0.000945	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—EGFR—malignant glioma	0.000122	0.000931	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000118	0.000907	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KRAS—malignant glioma	0.000115	0.000879	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000115	0.000878	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP9—malignant glioma	0.000107	0.000822	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ASMT—malignant glioma	0.000105	0.000803	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RTEL1—malignant glioma	9.97e-05	0.000763	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—BCAN—malignant glioma	9.87e-05	0.000755	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTP1—malignant glioma	9.86e-05	0.000755	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	9.72e-05	0.000744	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—malignant glioma	9.64e-05	0.000738	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—STAT3—malignant glioma	9.54e-05	0.000731	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—COX8A—malignant glioma	9.52e-05	0.000729	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EGFR—malignant glioma	8.67e-05	0.000664	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	8.51e-05	0.000652	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TNF—malignant glioma	8.26e-05	0.000632	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KRAS—malignant glioma	8.19e-05	0.000627	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ASMT—malignant glioma	8.1e-05	0.00062	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—IDH2—malignant glioma	7.95e-05	0.000609	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7.91e-05	0.000606	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—BCAN—malignant glioma	7.61e-05	0.000583	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2B6—malignant glioma	7.48e-05	0.000572	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—IDH1—malignant glioma	6.84e-05	0.000524	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SPHK1—malignant glioma	6.62e-05	0.000507	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP2C18—malignant glioma	6.48e-05	0.000496	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—malignant glioma	6.15e-05	0.000471	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—IDH2—malignant glioma	6.14e-05	0.00047	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.79e-05	0.000443	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2B6—malignant glioma	5.77e-05	0.000442	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—COX8A—malignant glioma	5.73e-05	0.000438	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—IDH1—malignant glioma	5.28e-05	0.000404	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTT1—malignant glioma	5.24e-05	0.000401	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SPHK1—malignant glioma	5.11e-05	0.000391	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP2C18—malignant glioma	5e-05	0.000383	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS1—malignant glioma	4.91e-05	0.000376	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ASMT—malignant glioma	4.87e-05	0.000373	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.72e-05	0.000361	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—BCAN—malignant glioma	4.58e-05	0.00035	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—BCHE—malignant glioma	4.57e-05	0.00035	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC5A5—malignant glioma	4.51e-05	0.000345	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.3e-05	0.000329	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.15e-05	0.000317	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTT1—malignant glioma	4.05e-05	0.00031	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS1—malignant glioma	3.79e-05	0.00029	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.78e-05	0.000289	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—IDH2—malignant glioma	3.69e-05	0.000282	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—malignant glioma	3.63e-05	0.000278	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CAT—malignant glioma	3.54e-05	0.000271	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—BCHE—malignant glioma	3.52e-05	0.00027	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC5A5—malignant glioma	3.48e-05	0.000266	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.47e-05	0.000266	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NCOR1—malignant glioma	3.34e-05	0.000256	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.29e-05	0.000252	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.26e-05	0.00025	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—IDH1—malignant glioma	3.17e-05	0.000243	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SPHK1—malignant glioma	3.07e-05	0.000235	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.01e-05	0.00023	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.84e-05	0.000218	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—malignant glioma	2.8e-05	0.000215	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CAT—malignant glioma	2.73e-05	0.000209	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CAV1—malignant glioma	2.72e-05	0.000208	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NCOR1—malignant glioma	2.58e-05	0.000197	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CG—malignant glioma	2.48e-05	0.00019	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTT1—malignant glioma	2.43e-05	0.000186	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPARG—malignant glioma	2.39e-05	0.000183	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS1—malignant glioma	2.28e-05	0.000175	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CD—malignant glioma	2.18e-05	0.000167	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—BCHE—malignant glioma	2.12e-05	0.000162	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CAV1—malignant glioma	2.1e-05	0.000161	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.09e-05	0.00016	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.01e-05	0.000154	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.91e-05	0.000146	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CB—malignant glioma	1.9e-05	0.000145	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—malignant glioma	1.88e-05	0.000144	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPARG—malignant glioma	1.85e-05	0.000141	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—malignant glioma	1.69e-05	0.000129	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.68e-05	0.000129	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTEN—malignant glioma	1.64e-05	0.000126	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CAT—malignant glioma	1.64e-05	0.000126	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOR1—malignant glioma	1.55e-05	0.000119	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.47e-05	0.000112	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—malignant glioma	1.45e-05	0.000111	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTEN—malignant glioma	1.27e-05	9.7e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CAV1—malignant glioma	1.26e-05	9.67e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.16e-05	8.87e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.15e-05	8.81e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPARG—malignant glioma	1.11e-05	8.5e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.01e-05	7.74e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—malignant glioma	9.46e-06	7.24e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—malignant glioma	8.94e-06	6.84e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.82e-06	6.75e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—malignant glioma	8.74e-06	6.69e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTEN—malignant glioma	7.62e-06	5.83e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—malignant glioma	7.3e-06	5.59e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.37e-06	4.11e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—malignant glioma	4.39e-06	3.36e-05	CbGpPWpGaD
